Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Global, Regional, and National Burden of Gastro-Oesophageal Reflux Disease in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 Publisher Pubmed



Dirac MA1, 4 ; Safiri S5, 6 ; Tsoi D1 ; Adedoyin RA8 ; Afshin A1, 2 ; Akhlaghi N10 ; Alahdab F11 ; Almulhim AM12 ; Amini S14 ; Ausloos F15 ; Bacha U16 ; Banach M17, 18 ; Bhagavathula AS19, 20 ; Bijani A21 Show All Authors
Authors
  1. Dirac MA1, 4
  2. Safiri S5, 6
  3. Tsoi D1
  4. Adedoyin RA8
  5. Afshin A1, 2
  6. Akhlaghi N10
  7. Alahdab F11
  8. Almulhim AM12
  9. Amini S14
  10. Ausloos F15
  11. Bacha U16
  12. Banach M17, 18
  13. Bhagavathula AS19, 20
  14. Bijani A21
  15. Biondi A24
  16. Borzi AM23
  17. Colombara D1, 66
  18. Dagnew B25
  19. Daryani A28
  20. Davitoiu DV29, 30
  21. Demeke FM31
  22. Demoz GT32, 35
  23. Do HP36
  24. Etemadi A37, 40
  25. Farzadfar F39
  26. Fischer F41
  27. Gebre AK45
  28. Gebremariam H42
  29. Gebremichael B46
  30. Ghashghaee A48
  31. Ghoshal UC51
  32. Hamidi S52
  33. Hasankhani M7
  34. Hassan S53
  35. Hay SI1, 2
  36. Hoang CL36
  37. Hole MK54
  38. Ikuta KS1, 3
  39. Ilesanmi OS55
  40. Irvani SSN57
  41. James SL1
  42. Joukar F58
  43. Kabir A49
  44. Kassaye HG59
  45. Kavetskyy T61, 62
  46. Kengne AP63, 64
  47. Khalilov R65
  48. Khan MU66
  49. Khan EA67
  50. Khan M68
  51. Khater A69
  52. Kimokoti RW70
  53. Koyanagi A71, 72
  54. Manda AL73
  55. Mehta D74
  56. Mehta V75
  57. Meretoja TJ76, 77
  58. Mestrovic T78, 79
  59. Mirrakhimov EM80, 81
  60. Mithra P82
  61. Mohammadianhafshejani A83
  62. Mohammadookhorasani M84
  63. Mokdad AH1, 2
  64. Moossavi M85
  65. Moradi G86, 87
  66. Mustafa G88, 89
  67. Naimzada MD90, 91
  68. Nasserimoghaddam S38
  69. Nazari J13, 92
  70. Negoi I29, 93
  71. Nguyen CT94
  72. Nguyen HLT94
  73. Nixon MR1
  74. Olum S95, 96
  75. Pourshams A38
  76. Poustchi H38
  77. Rabiee M97, 98
  78. Rabiee N97, 98
  79. Rafiei A26, 27
  80. Rawaf S99, 101
  81. Rawaf DL100, 102
  82. Roberts NLS1
  83. Roshandel G38, 103
  84. Safari S56
  85. Salimzadeh H38
  86. Sartorius B2, 104
  87. Sarveazad A47
  88. Sepanlou SG38, 105
  89. Sharifi A103
  90. Soheili A106, 107
  91. Suleria HAR108
  92. Tadesse DB33, 109
  93. Tela FGG44
  94. Tesfay BE60
  95. Thakur B110, 111
  96. Tran BX112
  97. Vacante M24
  98. Vahedi P113
  99. Veisani Y114
  100. Vos T1, 2
  101. Vosoughi K9, 50
  102. Werdecker A115, 116
  103. Wondmieneh AB34, 117
  104. Yeshitila YG118
  105. Zamani M22
  106. Zewdie KA43
  107. Zhang ZJ119
  108. Malekzadeh R38, 105
  109. Naghavi M1, 2

Source: The Lancet Gastroenterology and Hepatology Published:2020


Abstract

Background: Gastro-oesophageal reflux disease is a common chronic ailment that causes uncomfortable symptoms and increases the risk of oesophageal adenocarcinoma. We aimed to report the burden of gastro-oesophageal reflux disease in 195 countries and territories between 1990 and 2017, using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. Methods: We did a systematic review to identify measurements of the prevalence of gastro-oesophageal reflux disease in geographically defined populations worldwide between 1990 and 2017. These estimates were analysed with DisMod-MR, a Bayesian mixed-effects meta-regression tool that incorporates predictive covariates and adjustments for differences in study design in a geographical cascade of models. Fitted values for broader geographical units inform prior distributions for finer geographical units. Prevalence was estimated for 195 countries and territories. Reports of the frequency and severity of symptoms among individuals with gastro-oesophageal reflux disease were used to estimate the prevalence of cases with no, mild to moderate, or severe to very severe symptoms at a given time; these estimates were multiplied by disability weights to estimate years lived with disability (YLD). Findings: Data to estimate gastro-oesophageal reflux disease burden were scant, totalling 144 location-years (unique measurements from a year and location, regardless of whether a study reported them alongside measurements for other locations or years) of prevalence data. These came from six (86%) of seven GBD super-regions, 11 (52%) of 21 GBD regions, and 39 (20%) of 195 countries and territories. Mean estimates of age-standardised prevalence for all locations in 2017 ranged from 4408 cases per 100 000 population to 14 035 cases per 100 000 population. Age-standardised prevalence was highest (>11 000 cases per 100 000 population) in the USA, Italy, Greece, New Zealand, and several countries in Latin America and the Caribbean, north Africa and the Middle East, and eastern Europe; it was lowest (<7000 cases per 100 000 population) in the high-income Asia Pacific, east Asia, Iceland, France, Denmark, and Switzerland. Global prevalence peaked at ages 75–79 years, at 18 820 (95% uncertainty interval [95% UI] 13 770–24 000) cases per 100 000 population. Global age-standardised prevalence was stable between 1990 and 2017 (8791 [95% UI 7772–9834] cases per 100 000 population in 1990 and 8819 [7781–9863] cases per 100 000 population in 2017, percentage change 0·3% [–0·3 to 0·9]), but all-age prevalence increased by 18·1% (15·6–20·4) between 1990 and 2017, from 7859 (6905–8851) cases per 100 000 population in 1990 to 9283 (8189–10 400) cases per 100 000 population in 2017. YLDs increased by 67·1% (95% UI 63·5–70·3) between 1990 and 2017, from 3·60 million (1·93–6·12) in 1990 to 6·01 million (3·22–10·19) in 2017. Interpretation: Gastro-oesophageal reflux disease is common worldwide, although less so in much of eastern Asia. The stability of our global age-standardised prevalence estimates over time suggests that the epidemiology of the disease has not changed, but the estimates of all-age prevalence and YLDs, which increased between 1990 and 2017, suggest that the burden of gastro-oesophageal reflux disease is nonetheless increasing as a result of ageing and population growth. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Other Related Docs